We are live on ! Find out more
PAM

Private Asset Management Portfolio holdings

AUM $426M
1-Year Est. Return 20.27%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+20.27%
3 Year Est. Return
+38.16%
5 Year Est. Return
+67.56%
10 Year Est. Return
+177.32%
AUM
$629M
AUM Growth
+$4.83M
Cap. Flow
+$1.77M
Cap. Flow %
0.28%
Top 10 Hldgs %
35%
Holding
153
New
9
Increased
41
Reduced
53
Closed
8

Top Buys

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$6.81M
2
FCX icon
Freeport-McMoran
FCX
+$1.51M
3
T icon
AT&T
T
+$1.41M
4
PNR icon
Pentair
PNR
+$1.16M
5
WYNN icon
Wynn Resorts
WYNN
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 15.39%
3 Energy 12.83%
4 Financials 11.28%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
1
Qualcomm
QCOM
$155B
$57.3M 9.11%
771,090
-731
-0.1% -$53.5K
KMI icon
2
Kinder Morgan
KMI
$71.7B
$22.4M 3.55%
528,431
+172,992
+49% +$6.81M
GE icon
3
GE Aerospace
GE
$374B
$21M 3.34%
173,760
-350
-0.2% -$43K
CVX icon
4
Chevron
CVX
$392B
$20.7M 3.29%
184,656
+1,869
+1% +$212K
XOM icon
5
ExxonMobil
XOM
$644B
$17.7M 2.82%
191,698
+702
+0.4% +$65.5K
PFE icon
6
Pfizer
PFE
$143B
$17.6M 2.8%
596,498
-1,901
-0.3% -$54.5K
JNJ icon
7
Johnson & Johnson
JNJ
$618B
$16.5M 2.62%
157,512
-7,108
-4% -$749K
INTC icon
8
Intel
INTC
$455B
$16.5M 2.62%
453,681
-28,180
-6% -$980K
IBM icon
9
IBM
IBM
$211B
$15.3M 2.43%
99,647
+5,944
+6% +$946K
BAC icon
10
Bank of America
BAC
$435B
$15.3M 2.43%
853,614
-14,578
-2% -$249K
MRK icon
11
Merck
MRK
$322B
$14.5M 2.3%
267,365
+4,885
+2% +$272K
JPM icon
12
JPMorgan Chase
JPM
$935B
$13.7M 2.17%
218,155
+3,164
+1% +$190K
HD icon
13
Home Depot
HD
$331B
$12.6M 2.01%
120,375
-1,735
-1% -$169K
C icon
14
Citigroup
C
$222B
$12.3M 1.96%
228,087
+5,430
+2% +$288K
RTX icon
15
RTX Corp
RTX
$290B
$12M 1.9%
165,537
+3,202
+2% +$218K
AAPL icon
16
Apple
AAPL
$4.54T
$11.9M 1.89%
430,980
-34,032
-7% -$926K
GILD icon
17
Gilead Sciences
GILD
$162B
$11.8M 1.88%
125,434
+1,580
+1% +$163K
CL icon
18
Colgate-Palmolive
CL
$73.1B
$11M 1.75%
158,848
-1,603
-1% -$108K
BMY icon
19
Bristol-Myers Squibb
BMY
$133B
$10.6M 1.68%
178,767
-2,033
-1% -$115K
FCX icon
20
Freeport-McMoran
FCX
$90B
$10.3M 1.64%
441,034
+54,567
+14% +$1.51M
SIAL
21
DELISTED
SIGMA - ALDRICH CORP
SIAL
$10.3M 1.63%
74,765
-2,330
-3% -$317K
TEVA icon
22
Teva Pharmaceuticals
TEVA
$40.8B
$10.1M 1.61%
176,143
-3,719
-2% -$207K
ORCL icon
23
Oracle
ORCL
$374B
$9.57M 1.52%
212,905
+1,916
+0.9% +$78K
T icon
24
AT&T
T
$159B
$9.54M 1.52%
376,054
+54,319
+17% +$1.41M
EMC
25
DELISTED
EMC CORPORATION
EMC
$9.42M 1.5%
316,615
-3,625
-1% -$106K

Similar funds

Private Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Private Asset Management held 153 positions worth $629M, up 0.77% from $625M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Private Asset Management's Q4 2014 filing shows 9 new, 41 increased, 53 reduced and 8 closed positions. Its largest new stake was Adamas Pharmaceuticals: 47,690 shares worth $828K. The largest sale was EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART, an estimated $6.95M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Energy.

  • Private Asset Management's largest Q4 2014 buy was Adamas Pharmaceuticals: 47,690 shares worth $828K.
  • Private Asset Management added most to Kinder Morgan in Q4 2014, an estimated $6.81M increase.
  • Private Asset Management's biggest Q4 2014 reduction was Yum! Brands, cutting an estimated $1.75M.
  • Private Asset Management fully exited EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART in Q4 2014, selling an estimated $6.95M.
  • Private Asset Management's ten largest holdings make up 35% of its $629M portfolio in Q4 2014.
  • Private Asset Management opened 9 new positions and closed 8 in Q4 2014.
  • Private Asset Management's portfolio value rose 0.77% quarter-over-quarter to $629M.

Based on Private Asset Management's 13F filing for Q4 2014, filed 12 Jan 2015.